Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A

相似書籍

• Hemophilia A and B: molecular and clinical similarities and differences
  由: Castaman, Giancarlo, et al.
  出版: (2019)
• Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
  由: Linari, Silvia, et al.
  出版: (2020)
• Hemophilia management: Huge impact of a tiny difference
  由: Kloosterman, Fabienne, et al.
  出版: (2020)
• The higher prevalence of missense mutations in hemophilia B compared to hemophilia A could be important in determining a milder clinical phenotype in patients with severe hemophilia B
  由: Melchiorre, Daniela, et al.
  出版: (2016)
• Molecular Mechanisms of Inhibitor Development in Hemophilia
  由: Tieu, Paul, et al.
  出版: (2020)